Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting.

Johnston, Jennifer; Lintzeris, Nicholas; Allsop, David J; Suraev, Anastasia; Booth, Jessica; Carson, Dean S; Helliwell, David; Winstock, Adam; McGregor, Iain S

Johnston, Jennifer; Lintzeris, Nicholas; Allsop, David J; Suraev, Anastasia; Booth, Jessica; Carson, Dean S; Helliwell, David; Winstock, Adam; McGregor, Iain S.

Affiliation

Johnston J; Discipline of Addiction Medicine, University of Sydney, Camperdown, NSW, 2050, Australia.

Psychopharmacology (Berl) ; 231(24): 4623-36, 2014 Dec.

Article in En | MEDLINE | ID: mdl-24880749

Subject(s)

Antipsychotic Agents/therapeutic use; Cannabis/adverse effects; Lithium Carbonate/therapeutic use; Substance Withdrawal Syndrome/drug therapy; Adult; Appetite; Cannabinoids/blood; Double-Blind Method; Female; Humans; Inpatients; Male; Marijuana Smoking; Middle Aged; Oxytocin/blood; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Substance Withdrawal Syndrome / Antipsychotic Agents / Cannabis / Lithium Carbonate Type of study: Clinical_trials Language: En Journal: Psychopharmacology (Berl) Year: 2014 Type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google